EY advises Alantra on Dental Laboratory Platform expansion

EY Abogados has once again advised Alantra Private Equity in its strategic acquisition of four additional dental laboratories, further consolidating a nationwide network of nearly 20 laboratories across Spain. This move reinforces Alantra’s leadership in the dental laboratory sector and sets the stage for future European expansion.

The newly acquired laboratories specialize in fixed and removable prosthetics, aesthetic treatments, and orthodontics, leveraging advanced digital technologies to enhance precision in design and deliver superior services to dentists and patients alike. Serving primarily independent dental clinics, these laboratories bring extensive expertise and innovation to the growing group.

A unique aspect of the transaction is the involvement of the laboratory owners, who not only sell their businesses but also reinvest in Alantra’s global project, aligning their interests with the growth and success of the consolidated group. Alantra aims to continue expanding its platform, targeting new laboratories in Spain and exploring opportunities in other European markets.

EY Abogados provided comprehensive legal counsel throughout the transaction. The team was led by Susana Gómez Badiola (Partner), supported by Ignacio Sevilla (Senior Manager) and Jorge Garín (Manager). Furthermore, Susana and Jorge have been appointed as Secretary Non-Director and Vicesecretary Non-Director of the newly consolidated group, respectively, reflecting EY’s integral role in supporting Alantra’s vision.

This acquisition marks a significant milestone in Alantra’s strategic growth, underscoring the potential of combining sectoral expertise with cutting-edge digital capabilities to drive innovation and scalability in the dental industry.